Nine UBC faculty members have been announced as Fellows of the Canadian Academy of Health Sciences.
citations courtesy of CAHS
UBC 2020 CAHS FELLOWS
Obstetrics & Gynaecology, Women’s Health Research Institute
Dr. Lori Brotto is internationally recognized as a leader in sexual health research. She has led teams to develop and establish effective psychological interventions to improve sexual dysfunction and genital pain, which collectively affect up to a third of women. Her work has influenced practice around the world, with mindfulness being implemented in sexual medicine centres and in international guidelines. In recognition of her contributions to the field, she is a Canada Research Chair in women’s sexual health and received the Researcher of the Year (2017) award from the Society for Obstetricians and Gynaecologists Canada.
School of Population and Public Health
Dr. Bryan’s international reputation is in health economics, health technology assessment and health services and policy research. He was a Harkness Fellow in 2005 at Stanford University, has a career total of over 250 peer-reviewed articles, has won over $45M in research funding during his 12 years in Canada, and currently chairs the Advisory Board for CIHR’s Institute for Health Services & Policy Research. Dr. Bryan is an experienced and accomplished health research leader, having held numerous leadership roles throughout his career, culminating in his appointment in January 2020 as President of the BC Academic Health Science Network.
Pediatrics, BC Children’s and Women’s Hospital
Dr. Allison Eddy is Professor & Head of Pediatrics, University of British Columbia and Chief, Pediatric Medicine, BC Children’s & Women’s Hospital. She has held prior faculty positions at U. Toronto (12 years) and U. Washington (15 years), also serving as the Director of a NIH‐funded Child Health Research Center (UW) and the inaugural Director of the Tissue and Cell Sciences Research Center at Seattle Children’s Research Institute. Dr. Eddy is internationally recognized for her basic research discoveries on the cellular and molecular mechanisms of kidney fibrosis and for training the next generation of academic pediatricians and kidney specialists.
Dr. Haapasalo is Professor of Endodontics at UBC and a clinical endodontist who has focused his research on agents for disinfecting dental root canals and oral biofilm. He has authored two textbooks, eight book chapters, over 230 peer-reviewed articles, and supervised many graduate students. He is former editor-in-chief of Endodontic Topics, a former associate editor of the Journal of Endodontics, and serves on the editorial boards of dentistry’s highest-ranking scholarly journals. Dr. Haapasalo received numerous research and teaching awards, including in 2019 the most prestigious endodontic AAE Louis I Grossman Award for extraordinary research contributions to his discipline.
Pathology and Laboratory Medicine, BC Cancer Research Centre
Dr. Huntsman is a pathologist and clinical molecular geneticist. Through a combination of genetic and pathology approaches, Dr. Huntsman has redefined our understanding of ovarian and several rare cancers, including hereditary stomach cancer, leading to significant improvements in management. He proposed, developed, and promulgated the subtype-specific approach to ovarian cancer research, prevention, and treatment that is now the international standard. He discovered the key mutations in several ovarian cancer subtypes. His research has been published in prestigious journals, is highly cited, and is the basis of clinical innovations used in Canada and internationally.
Raymond W. Lam
Psychiatry, Vancouver Coastal Health Research Institute
Dr. Lam is Professor and BC Leadership Chair in Depression Research at the University of British Columbia. He is internationally recognized for his clinical research in depression and its treatments. His studies pioneered light therapy as an evidenced-based, nonpharmacological treatment for seasonal and nonseasonal depression. He led development of Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for depression that are widely used internationally, and global mental health initiatives through the Asia-Pacific Economic Cooperation (APEC), focusing on digital and mobile health technology solutions. He is a highly cited scientist and has published almost 400 peer-reviewed papers and 11 books.
Dentistry, BC Children's Hospital
Dr. Richman is a specialist in Pediatric Dentistry with a PhD in developmental biology from University College London. She is known internationally for her discoveries in facial development and tooth replacement with funding support from the CIHR, NSERC and the NIH. Dr. Richman is an Associate Editor for the Journal of Dental Research. She served on the board of the International Association for Dental Research as well as on the executive of the Canadian Association for Dental Research. Dr. Richman is the Director of the Graduate Program in Pediatric Dentistry at UBC, and treats children with complex disorders at BC Children’s Hospital.
Lakshmi N. Yatham
Psychiatry, Vancouver Coastal and Providence Health Care Authorities
Dr. Lakshmi Yatham is Professor and Head of the UBC Department of Psychiatry, Director of the UBC Institute of Mental Health, and Regional Head of Psychiatry for Vancouver Coastal and Providence Health Care Authorities. He is also Editor-in-Chief for the Canadian Journal of Psychiatry, and President of the World Federation of Societies of Biological Psychiatry. Dr. Yatham is a world-class clinician scientist in mood disorders who has made fundamental advancements to the understanding of the neurobiology and treatment of bipolar disorder. He is a highly cited researcher and has won numerous prestigious awards from national and international organizations.
Biomedical Engineering, Michael Smith Laboratories
Dr. Peter Zandstra is internationally recognized for his distinguished contributions to the field of biomedical engineering and is advancing our fundamental understanding of how stem cells develop into mature blood cells. Using this knowledge to design and implement new technologies that enable stem cell-based therapies for diseases such as leukemia, Dr. Zandstra is driving the development and clinical testing of these new therapies with Canadian biotechnology companies. A leader in cell and gene therapy manufacturing, Dr. Zandstra is catalyzing the growth of biomedical engineering research and education, across Canada and around the world.